Details of the Drug

General Information of Drug (ID: DMELPGC)

Drug Name
RG6206
Indication
Disease Entry ICD 11 Status REF
Duchenne dystrophy 8C70 Phase 2/3 [1]
Cross-matching ID
TTD ID
D0RP5T

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)